HCPCS Level II · Section Q
Q5117 Inj., kanjinti, 10 mg
Full Description
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
- Code
Q5117- Short Description
- Inj., kanjinti, 10 mg
- Section
- Q — Miscellaneous Services
- Pricing Indicator
51
Source: CMS HCPCS October 2026 quarterly release.
Last reviewed: September 2026